Literature DB >> 2904007

Plasma dopamine beta-hydroxylase: rapid diagnostic test for recurrent hereditary polyserositis.

M H Barakat1, K A Gumaa, L N Malhas, N I el-Sobki, M A Moussa, F F Fenech.   

Abstract

The diagnosis of recurrent hereditary polyserositis (RHP; also known as familial Mediterranean fever) remains one of exclusion since there has been no specific diagnostic laboratory test. A previous study suggested that the disorder is related to abnormal catecholamine metabolism. Plasma dopamine beta-hydroxylase (DBH) activity was assayed spectrophotometrically in 91 RHP patients and 162 controls. The activity was significantly higher in untreated symptom-free patients and in patients with acute attacks, than in controls (mean [SEM] 155.8 [14.1] vs 43.3 [1.9] mumol/min/1 p less than 0.0001). Colchicine treatment reduced DBH activity to control levels. The test showed a high diagnostic accuracy and specificity for RHP, whether the patient was symptom-free or having an acute attack. Moreover, it is easy to carry out.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904007     DOI: 10.1016/s0140-6736(88)92893-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Recurrent hereditary polyserositis.

Authors:  G C Cook
Journal:  BMJ       Date:  1990-11-17

2.  Recurrent hereditary polyserositis.

Authors:  P G Broadbent; J G Raynes; K P McAdam; M H Anis
Journal:  BMJ       Date:  1991-02-09

3.  Elective laparoscopic appendectomy in patients with familial Mediterranean fever.

Authors:  P Reissman; A L Durst; A Rivkind; A Szold; E Ben-Chetrit
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

4.  A Hypothesis Regarding Neurosecretory Inhibition of Stress Mediators by Colchicine in Preventing Stress-Induced Familial Mediterranean Fever Attacks.

Authors:  Cengiz Korkmaz; Döndü Üsküdar Cansu; Güven Barıs Cansu
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.